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Lymphomas are solid tumors that arise from lymphoid tissue and present themselves as Hodgkin’s or non-Hodgkin’s lymphoma.
Particularly gastrointestinal lymphomas can be clinically confused with other gastrointestinal tumors as well as with diﬀuse and
inﬂammatory bowel disease. Early diagnosis and treatment bear vital importance in the management of lymphomas due to their
high proliferation rates. In this report, we are presenting a case which initially displayed clinical and radiological signs of Crohn’s
disease, but was eventually diagnosed as Burkitt’s lymphoma by laparotomy, and also we aim to underscore the importance of
diﬀerential diagnosis.
1.CaseReport
A 49-year-old male patient presented to our hospital because
of abdominal pain, nausea-vomiting, lack of appetite, and
weight loss (4kg in the past month). He had been suﬀering
abdominal pain in the past 3 weeks, which was localized in
the right-lower quadrant, and it was relievable by defecation.
During the past month, he had started to suﬀer diarrhea
with no mucus and occasional appearance of fresh blood in
the stool 2-3 times a day along with vomiting 1-2 times a
day. His history revealed no remarkable event other than a
hydatid cyst and simultaneous cholecystectomy operation 12
years previously. He had no history of immunosuppressive
treatment. Physical examination revealed an incisional scar
of 20cm in length starting from the xiphoid process and
extending parallel to the costal arch and towards the right
axillary line, along with a mass lesion of 22 × 14cm in size
with an upper border 3cm above the umbilicus and a lower
border extending to the suprapubic region which was solid,
deep, and painful upon palpation.
CBC results were as follows: WBC: 8400/µL; lymphocyte
count: 1800/µL; Hb: 10.20g/dL; MCV: 84.1fL; platelet:
527000/mm3. Biochemical proﬁle was normal. Sedimenta-
tion rate was 60mm/h, and CRP was 50mg/L. There was no
occult blood or parasite in the stool. Fecal culture showed
no pathogenic bacterial growth. CEA, CA19-9, and CA 72-4
values were normal. The patient was seronegative for anti-
HIV antibody and anti-EBV IgM and IgG. The patient was
admitted to our hospital based on the presumptive diagnosis
of Crohn’s disease, lymphoma, colon cancer, or abscess.
Abdominal ultrasonography displayed calciﬁcations lo-
cated in the segment VI of the liver (postoperative changes?)
and a 12cm long intestinal segment of 5cm total diameter
and 1.6cm thickness which was located superior to the blad-
der over the midline and left aspect of the midline (Figure 1).
Abdominal tomography demonstrated coarse calciﬁca-
tions associated with the previous operation in the posterior
aspect of the left liver lobe along with a heterogenous and
solid area of 11 × 6cm in size showing mild enhancement
after intravenous contrast administration around which the2 Case Reports in Medicine
Figure 1: Ultrasonographic image displaying solid areas consistent
with thickening of the intestinal wall in the right-lower quadrant.
Figure 2: Coronal reformatted multislice abdominal computed
tomography displaying a terminal ileum segment in the right-lower
quadrant with marked thickening when compared to the adjacent
ileal segments and showing mild enhancement after oral and intra-
venous contrast agent administration.
adjacent adipose tissue had a streaky appearance (Figure 2).
The center of the above-described lesion exhibited luminal
enhancement in the intestines. Since the lumen of the small
bowel was symmetrical, inﬂammation of the terminal ileum
anditscomplicationswereconsideredﬁrst.Adenocarcinoma
was ruled out based on the absence of luminal stenosis and
lack of marked contrast enhancement.
Figure 3: Barium small bowel passage radiogram displaying
marked wall thickening involving a 40cm long segment adjacent to
the terminal ileum, characterized by displacement of the adjacent
intestinal loops. No luminal irregularity, narrowing, or cavity for-
mation was observed. These ﬁndings were interpreted as terminal
ileal involvement of Crohn’s disease.
T h ep a t i e n tw a ss u b j e c t e dt ot o t a lc o l o n o s c o p y .I l e o c e c a l
valve was observed to be patent, and mucosa was found to be
edematous and mildly irregular. Terminal ileal mucosa was
severely edematous and granular. Due to the severe edema in
the terminal ileum, the colonoscope could not be advanced
further than 5cm. There was no ulcer in the terminal ileum
or ileocecal valve. Many biopsy samples were acquired from
the ileocecal valve and terminal ileum. The lumen and mu-
cosaofcecum,ascendingcolon,transversecolon,descending
colon, sigmoid colon, and rectum were normal. Anal canal
displayed internal hemorrhoids.
Biopsies derived from ileum and ileocecal valve revealed
chronic active nonspeciﬁc changes in two biopsy fragments
and ulceration on the surface. Other fragments demon-
strated edema and nonspeciﬁc inﬂammatory alterations.
Although therewasno granuloma, focalactive inﬂammation
was thought to be consistent with the Crohn’s disease.
Examination of the small bowel by barium contrast re-
vealed an approximately 4cm long segment that was extend-
ing proximally from cecum within the terminal ileum over
which adjacent intestinal segments were pushed away, valvu-
lae conniventes were indistinct, and small bowel mucosa
had a patchy irregular appearance. Radiographic ﬁndings
were thought to be consistent with Crohn’s disease as well
(Figure 3).
Mesalazine therapy was started at a dose of 4g/day.
During the treatment of the patient, abdominal pain and di-
arrhea showed a regression; however, they recurred after 2-3
daysofimprovement.Inspectionscarriedoutonadailybasis
revealed a remarkable and progressive increase in the size
of the palpable mass over the right-lower quadrant. Lower
extremity Doppler USG was performed due to diameter
difference in favour of the right leg. Doppler USG depicted
thrombosis in the right main femoral vein, deep femoral
vein, proximal aspect of the superﬁcial femoral vein, andCase Reports in Medicine 3
Figure 4: Macroscopic view of the mass resected from the terminal
ileum after laparotomy.
proximal aspect of the great saphenous vein. A ﬁlter was
placed into the vena cava inferior and low-molecular-weight
heparin therapy was started. Because overall health status
of the patient began to deteriorate progressively, he was
transferred to surgery department for laparotomy. During
the laparotomy, a tumoral lesion of approximately 20cm in
size was encountered in the ileum and resected (Figure 4).
Histopathologic analysis of the resected material showed a
malignantlymphomaconsistentwithCD20-positiveatypical
Burkitt’slymphoma.Thepatientdiedonthethirdpostopera-
tive day due to acute myocardial infarction and cardiac arrest
which did not respond to cardiopulmonary resuscitation.
2. Discussion
Lymphomas are solid tumors of the lymphoid tissue. They
are categorized in two groups as Hodgkin’s lymphoma and
non-Hodgkin’s lymphoma. Hodgkin’s lymphoma is rarely
encountered in the gastrointestinal system. Non-Hodgkin’s
lymphomas generally arise from lymph nodes, and the lym-
phomas originating from other organs are termed as extra-
nodal or primary lymphomas. More than 40% of extranodal
lymphomas are seen in the gastrointestinal system, partic-
ularly in the stomach and small bowel. Majority of those
are B-cell lymphomas. Most common ones are diﬀuse large
cell lymphoma and marginal zone lymphoma of mucosa-
associated lymphoid tissue (MALT). Other B-cell lymphom-
as are Burkitt’s lymphoma, mantle cell lymphoma, and fol-
licularlymphoma.1-2%ofadultnon-Hodgkin’slymphomas
are Burkitt’s lymphoma. Burkitt’s lymphoma is more fre-
quently encountered during the childhood and in HIV-
positive patients [1].
The association of Crohn’s disease and non-Hodgkin’s
lymphoma is a contentious issue. Some immunologic chan-
ges in Crohn’s disease are believed to create a predisposition
for lymphoma development. Maclaurin et al. determined
that lymphocyte reactivity against tumor cells was disrupted
in patients with Crohn’s disease [2]. Moreover, diseases
associated with chronic inﬂammation, such as Hashimoto’s
thyroiditis, myoepithelial sialoadenitis, Helicobacter-related
gastritis, rheumatoid arthritis, and Sj¨ ogren’s syndrome, gen-
erate a predisposition for lymphoma development, as well
[3]. Epstein-Barr virus (EBV) positivity increases in HIV-
positive cases and patients undergoing immunosuppressive
therapy. EBV reactivation and infection risk may be elevated
in patients receiving immunosuppressive therapy. In cases
where Crohn’s disease and lymphoma coexist, EBV infection
is encountered, as well [4, 5].
In the study of Lewis et al. which was conducted on
6605 Crohn’s disease, 10.391 ulcerative colitis, and 60.506
control cases, lymphoma risk was not found to be elevated
[6].Inanothermeta-analysispublishedlateronbyKandielet
al., non-Hodgkin’s lymphoma frequency was observed to be
4 times higher among inﬂammatory bowel disease patients
receiving azathioprine and/or 6-mercaptopurine [7].
Moreover, there are cases of lymphoma mimicking
Crohn’sdiseaseintheliterature.Hurlstonereportedanearly-
phase mantle cell lymphoma case macroscopically mimick-
ing Crohn’s disease in the terminal ileum [8]. McCullough et
al. determined a mantle zone lymphoma mimicking diffuse
inﬂammatory bowel disease which was diagnosed by im-
munohistochemical analysis [9].
There are similarities between small bowel lymphoma
and Crohn’s disease. In a study group, among radiological
examinations of 50 patients diagnosed with Crohn’s disease
and/or lymphoma, 12 patients were found to have lympho-
maassociatedwithCrohn’sdisease,anddiﬀerentialdiagnosis
for Crohn’s disease could not be established by radiography.
Authors reported that stenosis, aneurysmal dilatation, ulcer-
ation, ﬁstula formation, mesenteric mass, and other isolated
or discontinued lesions may be present in the terminal ileum
showing a nodular pattern and an inﬂammatory appearance
[10].
Another characteristic feature of this patient was the
complication of deep vein thrombosis. Lower extremity
Doppler USG performed due to diameter diﬀerence in fa-
vour of the right leg revealed thrombosis in the femoral and
saphenous veins. There is an elevated risk for thromboem-
bolism in both lymphoma and inﬂammatory bowel disease
[11,12].Mohrenetal.performedastudyon1038lymphoma
cases and found thromboembolism in 7.7% of the patients
[11].Zhouetal.conductedastudyon422patientsanddeter-
mined thromboembolism in 17.1% of them. The risk factors
for thromboembolism in multivariate logistic regression
analysiswerenotedtobefemalegender,elevatedhemoglobin
or creatinine levels, and chemotherapy with doxorubicin or
methotrexate [13].
In our case, both tomography and small bowel radio-
gramsshowedﬁndingsmimickingCrohn’sdisease.However,
the patient was subjected to urgent laparotomy due to pres-
ence of a palpable and rapidly growing mass lesion in the
right-lower quadrant, rapid deterioration of the overall
health status, and lack of clinical improvement despite me-
salazine therapy. During the laparotomy, a tumoral mass of4 Case Reports in Medicine
20cm in size was discovered and resected. Histopatho-
logic examination results of the mass were consistent with
Burkitt’s lymphoma.
Burkitt’s lymphoma is generally encountered during the
childhood period and in HIV-positive patients. Although it
may present with symptoms reminiscent of Crohn’s disease,
it should be borne in mind that in cases that have a rapidly
growing mass in the abdomen and fail to respond to me-
salazine therapy, there is a likelihood of lymphoma presence
which would require an explorative laparotomy for veriﬁca-
tion. Early diagnosis and treatment is of utmost importance
because of the high proliferation rates in lymphomas. To
the best of our knowledge, there is no Burkitt’s lymphoma
case mimicking Crohn’s disease in the literature. Our case
was deemed remarkable because of the presence of a
Burkitt’s lymphoma mimicking Crohn’s disease which was
complicated with thromboembolism, despite having no risk
factors for lymphoma development such as HIV positivity or
history of immunosuppressive drug use.
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